Exome Asset Management as of March 31, 2024
Portfolio Holdings for Exome Asset Management
Exome Asset Management holds 53 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 6.5 | $7.5M | 9.7k | 777.96 | |
| Dr Reddys Labs Adr (RDY) | 5.4 | $6.3M | 86k | 73.35 | |
| Beigene Sponsored Adr | 4.9 | $5.8M | 37k | 156.39 | |
| Cigna Corp (CI) | 4.8 | $5.6M | 15k | 363.19 | |
| Alpine Immune Sciences | 4.0 | $4.6M | 117k | 39.64 | |
| Tg Therapeutics (TGTX) | 3.0 | $3.5M | 230k | 15.21 | |
| Avidity Biosciences Ord (RNA) | 3.0 | $3.4M | 135k | 25.52 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 3.0 | $3.4M | 88k | 39.24 | |
| Dex (DXCM) | 2.9 | $3.4M | 25k | 138.70 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.7 | $3.1M | 275k | 11.30 | |
| Celldex Therapeutics Com New (CLDX) | 2.6 | $3.0M | 71k | 41.97 | |
| Geron Corporation (GERN) | 2.5 | $2.9M | 887k | 3.30 | |
| Aerovate Therapeutics (AVTE) | 2.5 | $2.9M | 99k | 29.57 | |
| Morphosys Sponsored Ads (MOR) | 2.4 | $2.8M | 155k | 18.14 | |
| Travere Therapeutics (TVTX) | 2.4 | $2.8M | 363k | 7.71 | |
| Krystal Biotech (KRYS) | 2.2 | $2.6M | 15k | 177.93 | |
| Intuitive Surgical Com New (ISRG) | 2.2 | $2.5M | 6.4k | 399.09 | |
| Tarsus Pharmaceuticals (TARS) | 2.1 | $2.4M | 66k | 36.35 | |
| Madrigal Pharmaceuticals (MDGL) | 1.8 | $2.1M | 7.9k | 267.04 | |
| Inozyme Pharma (INZY) | 1.8 | $2.1M | 273k | 7.66 | |
| Rhythm Pharmaceuticals (RYTM) | 1.7 | $2.0M | 46k | 43.33 | |
| Insmed Com Par $.01 (INSM) | 1.7 | $1.9M | 72k | 27.13 | |
| Elevation Oncology (ELEV) | 1.6 | $1.9M | 369k | 5.13 | |
| EXACT Sciences Corporation (EXAS) | 1.6 | $1.8M | 27k | 69.06 | |
| Cytokinetics Com New (CYTK) | 1.6 | $1.8M | 26k | 70.11 | |
| Regenxbio Inc equity us cm (RGNX) | 1.5 | $1.8M | 85k | 21.07 | |
| Biogen Idec (BIIB) | 1.5 | $1.8M | 8.2k | 215.63 | |
| Ocular Therapeutix (OCUL) | 1.5 | $1.8M | 194k | 9.10 | |
| Agios Pharmaceuticals (AGIO) | 1.5 | $1.8M | 60k | 29.24 | |
| Natera (NTRA) | 1.5 | $1.7M | 19k | 91.46 | |
| Penumbra (PEN) | 1.4 | $1.6M | 7.4k | 223.18 | |
| Guardant Health (GH) | 1.4 | $1.6M | 79k | 20.63 | |
| Olema Pharmaceuticals (OLMA) | 1.4 | $1.6M | 143k | 11.32 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.4 | $1.6M | 56k | 28.60 | |
| Bridgebio Pharma (BBIO) | 1.3 | $1.5M | 49k | 30.92 | |
| Terns Pharmaceuticals (TERN) | 1.3 | $1.5M | 228k | 6.56 | |
| Marinus Pharmaceuticals Com New (MRNS) | 1.3 | $1.5M | 163k | 9.04 | |
| Inari Medical Ord (NARI) | 1.2 | $1.4M | 30k | 47.98 | |
| Quanterix Ord (QTRX) | 1.2 | $1.4M | 60k | 23.56 | |
| Intra Cellular Therapies (ITCI) | 1.2 | $1.4M | 20k | 69.20 | |
| Shockwave Med | 1.1 | $1.3M | 4.0k | 325.63 | |
| Vyne Therapeutics (VYNE) | 1.1 | $1.3M | 415k | 3.07 | |
| Regulus Therapeutics (RGLS) | 1.0 | $1.2M | 403k | 2.88 | |
| Q32 Bio (QTTB) | 0.9 | $1.1M | 65k | 17.04 | |
| Zai Lab Adr (ZLAB) | 0.9 | $1.0M | 65k | 16.02 | |
| Enliven Therapeutics (ELVN) | 0.9 | $1.0M | 58k | 17.59 | |
| Ventyx Biosciences (VTYX) | 0.8 | $902k | 164k | 5.50 | |
| Ultragenyx Pharmaceutical (RARE) | 0.7 | $831k | 18k | 46.69 | |
| I Mab Sponsored Ads (IMAB) | 0.5 | $606k | 326k | 1.86 | |
| Adagene Ads (ADAG) | 0.4 | $435k | 155k | 2.80 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.3 | $330k | 61k | 5.42 | |
| Pacific Biosciences of California (PACB) | 0.2 | $282k | 75k | 3.75 | |
| Avrobio Ord (AVRO) | 0.1 | $78k | 61k | 1.28 |
